Your browser doesn't support javascript.
loading
Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals.
Wang, Shaoxun; Jiao, Feng; Border, Jane J; Fang, Xing; Crumpler, Reece F; Liu, Yedan; Zhang, Huawei; Jefferson, Joshua; Guo, Ya; Elliott, Parker S; Thomas, Kirby N; Strong, Luke B; Urvina, Austin H; Zheng, Baoying; Rijal, Arjun; Smith, Stanley V; Yu, Hongwei; Roman, Richard J; Fan, Fan.
Afiliação
  • Wang S; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Jiao F; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Border JJ; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Fang X; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Crumpler RF; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Liu Y; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Zhang H; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Jefferson J; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Guo Y; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Elliott PS; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Thomas KN; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Strong LB; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Urvina AH; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Zheng B; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Rijal A; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Smith SV; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Yu H; Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Roman RJ; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
  • Fan F; Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, Mississippi.
Am J Physiol Heart Circ Physiol ; 322(2): H246-H259, 2022 02 01.
Article em En | MEDLINE | ID: mdl-34951541
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sorbitol / Demência Vascular / Angiopatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sorbitol / Demência Vascular / Angiopatias Diabéticas / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article